GABAAReceptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism
- Rudolph, Uwe Laboratory of Genetic Neuropharmacology, McLean Hospital and Department of Psychiatry, Harvard Medical School, Belmont, Massachusetts 02478; email:
- Möhler, Hanns Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH) Zurich, CH-8057 Zurich, Switzerland; email:
Published in:
- Annual Review of Pharmacology and Toxicology. - Annual Reviews. - 2014, vol. 54, no. 1, p. 483-507
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1146/annurev-pharmtox-011613-135947
- ISSN 0362-1642
- Persistent URL
- https://susi.usi.ch/global/documents/119685
Statistics
Document views: 15
File downloads:
- fulltext.pdf: 0